APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell therapy platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell therapy platform Market Analysis and Forecast 2026-2032

Report ID 17408804025 June 2026257 pages

Choose your research edition.

Industry ResearchCell therapy platform Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell therapy platform Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Cell therapy platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell therapy platform Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell therapy platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global Cell therapy platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell therapy platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell therapy platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell therapy platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell therapy platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell therapy platform include Novartis, Gilead Sciences, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Roche, Bluebird Bio, Cellectis, Sangamo Therapeutics and Fate Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell therapy platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell therapy platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell therapy platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell therapy platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell therapy platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell therapy platform revenue, projected growth trends, production technology, application and end-user industry.

Cell therapy platform Segment by Company

Novartis

Gilead Sciences

Regeneron Pharmaceuticals

Takeda Pharmaceuticals

Roche

Bluebird Bio

Cellectis

Sangamo Therapeutics

Fate Therapeutics

Cell therapy platform Segment by Type

Autologous Cell Therapy Platform

Allogeneic Cell Therapy Platform

Others

Cell therapy platform Segment by Application

General Hospital

Specialized Hospital

Others

Cell therapy platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell therapy platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell therapy platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell therapy platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell therapy platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell therapy platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell therapy platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell therapy platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Autologous Cell Therapy Platform Major Player Table 3. Allogeneic Cell Therapy Platform Major Player Table 4. Others Major Player Table 5. Global Cell therapy platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. General Hospital Major Player Table 7. Specialized Hospital Major Player Table 8. Others Major Player Table 9. Cell therapy platform Industry Trends Table 10. Cell therapy platform Industry Drivers Table 11. Cell therapy platform Industry Opportunities and Challenges Table 12. Cell therapy platform Industry Restraints Table 13. Global Cell therapy platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cell therapy platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cell therapy platform Market Share by Region (2021-2026) Table 16. Global Cell therapy platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cell therapy platform Market Share by Region (2027-2032) Table 18. Global Cell therapy platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cell therapy platform Revenue Market Share by Players (2021-2026) Table 20. Global Cell therapy platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell therapy platform Key Players Headquarters & Area Served Table 22. Global Cell therapy platform Players, Product Type & Application Table 23. Global Cell therapy platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell therapy platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cell therapy platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell therapy platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cell therapy platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cell therapy platform Revenue Market Share by Type (2021-2026) Table 30. Global Cell therapy platform Revenue Market Share by Type (2027-2032) Table 31. Global Cell therapy platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell therapy platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cell therapy platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cell therapy platform Revenue Market Share by Application (2021-2026) Table 35. Global Cell therapy platform Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Cell therapy platform Product Portfolio Table 40. Novartis Recent Development Table 41. Gilead Sciences Company Information Table 42. Gilead Sciences Business Overview Table 43. Gilead Sciences Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Gilead Sciences Cell therapy platform Product Portfolio Table 45. Gilead Sciences Recent Development Table 46. Regeneron Pharmaceuticals Company Information Table 47. Regeneron Pharmaceuticals Business Overview Table 48. Regeneron Pharmaceuticals Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Regeneron Pharmaceuticals Cell therapy platform Product Portfolio Table 50. Regeneron Pharmaceuticals Recent Development Table 51. Takeda Pharmaceuticals Company Information Table 52. Takeda Pharmaceuticals Business Overview Table 53. Takeda Pharmaceuticals Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Takeda Pharmaceuticals Cell therapy platform Product Portfolio Table 55. Takeda Pharmaceuticals Recent Development Table 56. Roche Company Information Table 57. Roche Business Overview Table 58. Roche Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Roche Cell therapy platform Product Portfolio Table 60. Roche Recent Development Table 61. Bluebird Bio Company Information Table 62. Bluebird Bio Business Overview Table 63. Bluebird Bio Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bluebird Bio Cell therapy platform Product Portfolio Table 65. Bluebird Bio Recent Development Table 66. Cellectis Company Information Table 67. Cellectis Business Overview Table 68. Cellectis Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Cellectis Cell therapy platform Product Portfolio Table 70. Cellectis Recent Development Table 71. Sangamo Therapeutics Company Information Table 72. Sangamo Therapeutics Business Overview Table 73. Sangamo Therapeutics Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sangamo Therapeutics Cell therapy platform Product Portfolio Table 75. Sangamo Therapeutics Recent Development Table 76. Fate Therapeutics Company Information Table 77. Fate Therapeutics Business Overview Table 78. Fate Therapeutics Cell therapy platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Fate Therapeutics Cell therapy platform Product Portfolio Table 80. Fate Therapeutics Recent Development Table 81. North America Cell therapy platform Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Cell therapy platform Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Cell therapy platform Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Cell therapy platform Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Cell therapy platform Revenue by Country (2021-2026) & (US$ Million) Table 87. North America Cell therapy platform Revenue by Country (US$ Million) & (2027-2032) Table 88. Europe Cell therapy platform Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Cell therapy platform Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Cell therapy platform Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Cell therapy platform Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Cell therapy platform Revenue by Country (2021-2026) & (US$ Million) Table 94. Europe Cell therapy platform Revenue by Country (US$ Million) & (2027-2032) Table 95. China Cell therapy platform Revenue by Type (2021-2026) & (US$ Million) Table 96. China Cell therapy platform Revenue by Type (2027-2032) & (US$ Million) Table 97. China Cell therapy platform Revenue by Application (2021-2026) & (US$ Million) Table 98. China Cell therapy platform Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Cell therapy platform Revenue by Type (2021-2026) & (US$ Million) Table 100. Asia Cell therapy platform Revenue by Type (2027-2032) & (US$ Million) Table 101. Asia Cell therapy platform Revenue by Application (2021-2026) & (US$ Million) Table 102. Asia Cell therapy platform Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Cell therapy platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Cell therapy platform Revenue by Region (US$ Million) & (2021-2026) Table 105. Asia Cell therapy platform Revenue by Region (US$ Million) & (2027-2032) Table 106. SAMEA Cell therapy platform Revenue by Type (2021-2026) & (US$ Million) Table 107. SAMEA Cell therapy platform Revenue by Type (2027-2032) & (US$ Million) Table 108. SAMEA Cell therapy platform Revenue by Application (2021-2026) & (US$ Million) Table 109. SAMEA Cell therapy platform Revenue by Application (2027-2032) & (US$ Million) Table 110. SAMEA Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. SAMEA Cell therapy platform Revenue by Country (2021-2026) & (US$ Million) Table 112. SAMEA Cell therapy platform Revenue by Country (US$ Million) & (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Cell therapy platform Image Figure 2. Global Cell therapy platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell therapy platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Autologous Cell Therapy Platform Image Figure 5. Allogeneic Cell Therapy Platform Image Figure 6. Others Image Figure 7. Global Cell therapy platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cell therapy platform Market Size Share 2021 VS 2025 VS 2032 Figure 9. General Hospital Image Figure 10. Specialized Hospital Image Figure 11. Others Image Figure 12. Global Cell therapy platform Market Size (US$ Million) & (2021-2032) Figure 13. Global Cell therapy platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell therapy platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cell therapy platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell therapy platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell therapy platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cell therapy platform Revenue Market Share by Type (2021-2032) Figure 20. Global Cell therapy platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell therapy platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cell therapy platform Revenue Market Share by Application (2021-2032) Figure 23. North America Cell therapy platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cell therapy platform Revenue Share by Type (2021-2032) Figure 25. North America Cell therapy platform Revenue Share by Application (2021-2032) Figure 26. North America Cell therapy platform Revenue Share by Country (2021-2032) Figure 27. United States Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cell therapy platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cell therapy platform Revenue Share by Type (2021-2032) Figure 32. Europe Cell therapy platform Revenue Share by Application (2021-2032) Figure 33. Europe Cell therapy platform Revenue Share by Country (2021-2032) Figure 34. Germany Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cell therapy platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cell therapy platform Revenue Share by Type (2021-2032) Figure 44. China Cell therapy platform Revenue Share by Application (2021-2032) Figure 45. Asia Cell therapy platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cell therapy platform Revenue Share by Type (2021-2032) Figure 47. Asia Cell therapy platform Revenue Share by Application (2021-2032) Figure 48. Asia Cell therapy platform Revenue Share by Region (2021-2032) Figure 49. Japan Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cell therapy platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cell therapy platform Revenue Share by Type (2021-2032) Figure 57. SAMEA Cell therapy platform Revenue Share by Application (2021-2032) Figure 58. SAMEA Cell therapy platform Revenue Share by Country (2021-2032) Figure 59. Brazil Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cell therapy platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Cell Therapy Platform
  • Allogeneic Cell Therapy Platform
  • Others
Applications
  • General Hospital
  • Specialized Hospital
  • Others
Companies covered
  • Novartis
  • Gilead Sciences
  • Regeneron Pharmaceuticals
  • Takeda Pharmaceuticals
  • Roche
  • Bluebird Bio
  • Cellectis
  • Sangamo Therapeutics
  • Fate Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell therapy platform Market by Type
  3. 1.2.1 Global Cell therapy platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Autologous Cell Therapy Platform
  5. 1.2.3 Allogeneic Cell Therapy Platform
  6. 1.2.4 Others
  7. 1.3 Cell therapy platform Market by Application
  8. 1.3.1 Global Cell therapy platform Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 General Hospital
  10. 1.3.3 Specialized Hospital
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cell therapy platform Market Dynamics
  1. 2.1 Cell therapy platform Industry Trends
  2. 2.2 Cell therapy platform Industry Drivers
  3. 2.3 Cell therapy platform Industry Opportunities and Challenges
  4. 2.4 Cell therapy platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell therapy platform Market Perspective (2021-2032)
  2. 3.2 Global Cell therapy platform Growth Trends by Region
  3. 3.2.1 Global Cell therapy platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell therapy platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell therapy platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell therapy platform Revenue by Players
  2. 4.1.1 Global Cell therapy platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell therapy platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell therapy platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell therapy platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell therapy platform Key Players Headquarters & Area Served
  7. 4.4 Global Cell therapy platform Players, Product Type & Application
  8. 4.5 Global Cell therapy platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell therapy platform Market CR5 and HHI
  11. 4.6.3 2025 Cell therapy platform Tier 1, Tier 2, and Tier 3
5 Cell therapy platform Market Size by Type
  1. 5.1 Global Cell therapy platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell therapy platform Revenue by Type (2021-2032)
  3. 5.3 Global Cell therapy platform Revenue Market Share by Type (2021-2032)
6 Cell therapy platform Market Size by Application
  1. 6.1 Global Cell therapy platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell therapy platform Revenue by Application (2021-2032)
  3. 6.3 Global Cell therapy platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Cell therapy platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Cell therapy platform Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Gilead Sciences
  8. 7.2.1 Gilead Sciences Company Information
  9. 7.2.2 Gilead Sciences Business Overview
  10. 7.2.3 Gilead Sciences Cell therapy platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Gilead Sciences Cell therapy platform Product Portfolio
  12. 7.2.5 Gilead Sciences Recent Developments
  13. 7.3 Regeneron Pharmaceuticals
  14. 7.3.1 Regeneron Pharmaceuticals Company Information
  15. 7.3.2 Regeneron Pharmaceuticals Business Overview
  16. 7.3.3 Regeneron Pharmaceuticals Cell therapy platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Regeneron Pharmaceuticals Cell therapy platform Product Portfolio
  18. 7.3.5 Regeneron Pharmaceuticals Recent Developments
  19. 7.4 Takeda Pharmaceuticals
  20. 7.4.1 Takeda Pharmaceuticals Company Information
  21. 7.4.2 Takeda Pharmaceuticals Business Overview
  22. 7.4.3 Takeda Pharmaceuticals Cell therapy platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Takeda Pharmaceuticals Cell therapy platform Product Portfolio
  24. 7.4.5 Takeda Pharmaceuticals Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Cell therapy platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Cell therapy platform Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Bluebird Bio
  32. 7.6.1 Bluebird Bio Company Information
  33. 7.6.2 Bluebird Bio Business Overview
  34. 7.6.3 Bluebird Bio Cell therapy platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bluebird Bio Cell therapy platform Product Portfolio
  36. 7.6.5 Bluebird Bio Recent Developments
  37. 7.7 Cellectis
  38. 7.7.1 Cellectis Company Information
  39. 7.7.2 Cellectis Business Overview
  40. 7.7.3 Cellectis Cell therapy platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cellectis Cell therapy platform Product Portfolio
  42. 7.7.5 Cellectis Recent Developments
  43. 7.8 Sangamo Therapeutics
  44. 7.8.1 Sangamo Therapeutics Company Information
  45. 7.8.2 Sangamo Therapeutics Business Overview
  46. 7.8.3 Sangamo Therapeutics Cell therapy platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sangamo Therapeutics Cell therapy platform Product Portfolio
  48. 7.8.5 Sangamo Therapeutics Recent Developments
  49. 7.9 Fate Therapeutics
  50. 7.9.1 Fate Therapeutics Company Information
  51. 7.9.2 Fate Therapeutics Business Overview
  52. 7.9.3 Fate Therapeutics Cell therapy platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Fate Therapeutics Cell therapy platform Product Portfolio
  54. 7.9.5 Fate Therapeutics Recent Developments
8 North America
  1. 8.1 North America Cell therapy platform Revenue (2021-2032)
  2. 8.2 North America Cell therapy platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell therapy platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell therapy platform Revenue by Type (2027-2032)
  5. 8.3 North America Cell therapy platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell therapy platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell therapy platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell therapy platform Revenue by Application (2027-2032)
  9. 8.5 North America Cell therapy platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell therapy platform Revenue by Country
  11. 8.6.1 North America Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell therapy platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell therapy platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell therapy platform Revenue (2021-2032)
  2. 9.2 Europe Cell therapy platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell therapy platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell therapy platform Revenue by Type (2027-2032)
  5. 9.3 Europe Cell therapy platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell therapy platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell therapy platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell therapy platform Revenue by Application (2027-2032)
  9. 9.5 Europe Cell therapy platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell therapy platform Revenue by Country
  11. 9.6.1 Europe Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell therapy platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell therapy platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell therapy platform Revenue (2021-2032)
  2. 10.2 China Cell therapy platform Revenue by Type (2021-2032)
  3. 10.2.1 China Cell therapy platform Revenue by Type (2021-2026)
  4. 10.2.2 China Cell therapy platform Revenue by Type (2027-2032)
  5. 10.3 China Cell therapy platform Revenue Share by Type (2021-2032)
  6. 10.4 China Cell therapy platform Revenue by Application (2021-2032)
  7. 10.4.1 China Cell therapy platform Revenue by Application (2021-2026)
  8. 10.4.2 China Cell therapy platform Revenue by Application (2027-2032)
  9. 10.5 China Cell therapy platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell therapy platform Revenue (2021-2032)
  2. 11.2 Asia Cell therapy platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell therapy platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell therapy platform Revenue by Type (2027-2032)
  5. 11.3 Asia Cell therapy platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell therapy platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell therapy platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell therapy platform Revenue by Application (2027-2032)
  9. 11.5 Asia Cell therapy platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell therapy platform Revenue by Country
  11. 11.6.1 Asia Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell therapy platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell therapy platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell therapy platform Revenue (2021-2032)
  2. 12.2 SAMEA Cell therapy platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell therapy platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell therapy platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell therapy platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell therapy platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell therapy platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell therapy platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell therapy platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell therapy platform Revenue by Country
  11. 12.6.1 SAMEA Cell therapy platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell therapy platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell therapy platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst